mRNA Therapeutics

Translating the message with MRTTM

The Role of mRNA

mRNA is a fundamental component of gene expression. It is the key link in the process of translating genetic information encoded in DNA into instructions that are used by cells to produce the proteins needed to carry out essential cellular functions. These instructions are processed through cellular mechanisms in two steps: transcription and translation. During transcription, a gene that encodes an amino acid sequence for a particular protein is transcribed into a complementary sequence of mRNA. The mRNA then carries these instructions to other areas of the cell where the instructions are translated by ribosomes, which are specialized molecular machines within cells that carry out protein synthesis. During translation, the ribosomes use the instructions conveyed by mRNA as a template for assembling the amino acids to create the desired protein.

DNA RNA Protein Panel

mRNA and Genetics Disease

Abnormal gene expression, caused by a mutation in a DNA sequence, can result in the transcription of defective instructions. The translation of defective instructions by the cell can lead to the failure to produce, insufficient production or over production of a protein, or the production of dysfunctional proteins. This protein defect is the underlying cause of genetic disease.

To treat these types of disease, mRNA therapies have a potentially powerful ability to regulate protein expression and restore health.

mRNA and Infectious Diseases

Pathogenic microorganisms, such as bacteria, viruses, parasites or fungi can cause infectious diseases that can be spread, directly or indirectly, from one person to another. To address an unwanted virus for example, an mRNA vaccine containing mRNA instructs certain cells in the body to build an antigen that will induce an immune response to a virus.

Our mRNA Investigational Medicines

Translate Bio is developing transformative mRNA therapies to treat diseases caused by protein or gene dysfunction, and to generate protective immunity in the case of vaccines.

We believe that our MRTTM platform is broadly applicable across multiple diseases in which the production of a desirable protein can have a therapeutic effect or where a desirable antigen can have a protective effect. We have observed successful production of desired proteins through multiple routes of administration in preclinical studies, which may allow us to develop MRTTM product candidates for the treatment of a wide range of rare and non-rare genetic diseases.

Advantages of mRNA Medicines

mRNA therapy is engineered to deliver mRNA encoding natural, functional proteins that replace defective or missing proteins, or generate protective immunity. mRNA medicines have potential advantages, including that it:

  • restores gene expression without entering the cell nucleus or changing the genome;
  • enables the treatment of diseases that were previously undruggable by using the cell’s own machinery to produce natural and fully functional proteins;
  • has drug-like properties that are familiar to health care providers, including the potential to repeat and adjust dosing in a chronic setting; and
  • permits rapid development from target gene selection to product candidate.

We are driven to pursue this technology because of its potential impact. mRNA’s central role in protein expression confers the potential for this approach to have broad applicability across multiple diseases in which the production of a desirable protein can have a therapeutic effect.

Scientific Platform

A transformative approach to mRNA therapeutics